Alliance Pharma agrees £362m takeover by biggest shareholder The deal will see shareholders get 64.75p a share, up from the original offer worth 62.5p a share, or £349.7 million. Evening Standard · Mar 10, 2025
Alliance Pharma to accept £349.7m buyout offer from biggest investor The deal would see the Aim-listed pharma firm leave the public markets, after several tumultuous years including a fine from the competition watchdog. Evening Standard · Jan 10, 2025
Alliance Pharma boss faces disqualification after CMA probe The healthcare firm denies conspiring to restrict the supply of anti-sickness drugs to the NHS Evening Standard · Sep 2, 2022